1-20 of 77
Tommaso Caravita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Italian Real-World Experience of Gilteritinib Monotherapy in Patients with Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Preliminary Results

Rosa Greco, Silvia Imbergamo, Elisabetta Pierdomenico, Barbara Di Camillo, Cristina Papayannidis, Elisabetta Todisco, Erika Borlenghi, Nicola Fracchiolla, Claudia Basilico, Monica Fumagalli, Patrizia Zappasodi, Mauro Turrini, Anna Candoni, Monia Lunghi, Maurizio Musso, Calogero Vetro, Fabio Guolo, Donato Mannina, Albana Lico, Anna Maria Scattolin, Gianpaolo Nadali, Monica Crugnola, Sara Galimberti, Francesco Marchesi, Elisabetta Metafuni, Tommaso Caravita di Toritto, Clara Minotti, Pellegrino Musto, Valentina Mancini, Marta Riva, Lorenzo Rizzo, Giovanni Grillo, Roberto Cairoli
Journal: Blood
Blood (2024) 144 (Supplement 1): 5188.
https://doi.org/10.1182/blood-2024-205427
Published: 2024
Journal Articles

Updated Analysis of a Prospective, Multicenter, Observational Study on the Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma

Massimo Offidani, Carmela Zizzo, Sonia More', Irene Federici, Alessandra Bossi, Valentina Maria Manieri, Maria Teresa Petrucci, Francesca Fazio, Chiara Lisi, Francesca Farina, Marino Brunori, Francesca Fioritoni, Nicola Sgherza, Rosa De Francesco, Tommaso Caravita di Toritto, Attilio Tordi, Angela Amendola, Assunta Melaccio, Silvia Gentili, Lucia Ciuffreda, Maria Livia Del Giudice, Antonietta Pia Falcone, Alessandro Gozzetti, Simona Tomassetti, Anna Mele, Miriana Ruggieri, Agostina Siniscalchi, Rosario Bianco, Antonino Greco, Antonio Giovanni Solimando, Francesco Rotondo, Fabio Trastulli, Laura Corvatta, Erika Morsia, Serena Rupoli, Shahram Kordasti, Attilio Olivieri, Giovanni Duro
Journal: Blood
Blood (2023) 142 (Supplement 1): 4713.
https://doi.org/10.1182/blood-2023-189193
Published: 2023
Journal Articles

Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study

Massimo Offidani, Carmela Zizzo, Serena Rupoli, Irene Federici, Sonia Morè, Alessandra Bossi, Valentina Maria Manieri, Maria Teresa Petrucci, Tommaso Caravita DI Toritto, Marino Brunori, Alessandro Gozzetti, Attilio Tordi, Francesca Fazio, Chiara Lisi, Assunta Melaccio, Lucia Ciuffreda, Antonietta Pia Falcone, Francesca Fioritoni, Silvia Gentili, Agostina Siniscalchi, Fabio Trastulli, Laura Corvatta, Erika Morsia, Attilio Olivieri, Giovanni Duro
Journal: Blood
Blood (2022) 140 (Supplement 1): 10027–10028.
https://doi.org/10.1182/blood-2022-168619
Published: 2022
Journal Articles

Relapsed/Refractory Multiple Myeloma Patients. a Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy

Francesca Fazio, Alice Di Rocco, Tommaso Za, Valeria Tomarchio, Angela Rago, Alfonso Piciocchi, Tommaso Caravita di Toritto, Ombretta Annibali, Valerio De Stefano, Robin Foa, Maurizio Martelli, Maria Teresa Petrucci
Journal: Blood
Blood (2021) 138 (Supplement 1): 3755.
https://doi.org/10.1182/blood-2021-149547
Published: 2021
Journal Articles

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D’Agostino, Massimo Offidani, Nicola Cascavilla, Andrea Capra, Giulia Benevolo, Patrizia Tosi, Monica Galli, Roberto Marasca, Nicola Giuliani, Annalisa Bernardini, Elisabetta Antonioli, Delia Rota-Scalabrini, Claudia Cellini, Alessandra Pompa, Federico Monaco, Francesca Patriarca, Tommaso Caravita di Toritto, Paolo Corradini, Paola Tacchetti, Mario Boccadoro, Sara Bringhen
Journal: Blood
Blood (2021) 137 (22): 3027–3036.
https://doi.org/10.1182/blood.2020009507
Published: 2021
Includes: Supplemental data
Journal Articles

On-Demand Plerixafor with Cyclophosphamide and G-CSF for Hematopoietic Stem-Cell Mobilization in Multiple Myeloma Patients: Preliminary Results of a Prospective Observational Study (MOZOBL06877)

Roberto Mina, MD, Francesca Bonello, Giuseppe Milone, Maria Teresa Petrucci, Chiara Nozzoli, Velia Bongarzoni, Andrea Capra, Francesco Pisani, Giusy Cetani, Alessandra Malfitano, Delia Rota Scalabrini, Stelvio Ballanti, Roberto M. Lemoli, Patrizia Tosi, Daniele Derudas, Tommaso Caravita di Toritto, Massimo Offidani, Pellegrino Musto, Paolo Corradini, Michele Cavo, Mario Boccadoro, Alessandra Larocca
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-136316
Published: 2020
Journal Articles

Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset

Gian Maria Zaccaria, PhD, Andrea Capra, Maria Teresa Petrucci, Massimo Offidani, Vittorio Montefusco, Francesco Di Raimondo, MD, Annalisa Bernardini, Anna Marina Liberati, Paola Omedé, Donato Mannina, Tommaso Caravita di Toritto, Vittorio Emanuele Muccio, Nicola Cascavilla, Stefania Montani, Francesca Patriarca, Giulia Benevolo, MD, Elona Saraci, Angelo Belotti, Gianluca Gaidano, MD PhD, Giorgina Specchia, MD, Arnon Nagler, MD MSc, Roman Hajek, Prof, MD PhD, Andrew Spencer, DM, Pieter Sonneveld, Mario Boccadoro, Francesca Gay, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2130.
https://doi.org/10.1182/blood-2019-125640
Published: 2019
Journal Articles

Long-Term Carfilzomib for High-Risk Patients with Newly Diagnosed Multiple Myeloma: A Pooled Analysis of Two Phase 1/2 Studies

Roberto Mina, MD, Alessandra Larocca, MD, Maria Teresa Petrucci, MD, Gianluca Gaidano, MD, Stelvio Ballanti, MD, Pellegrino Musto, MD, Massimo Offidani, MD, Paola Omedé, Giulia Benevolo, MD, Alessandra Malfitano, Piero Galieni, MD, Michele Cavo, MD, Tommaso Caravita di Toritto, MD, Vittorio Del Fabro, MD, Vittorio Montefusco, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Sara Bringhen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3240.
https://doi.org/10.1182/blood-2018-99-112075
Published: 2018
Journal Articles

Immunotherapy in Multiple Myeloma: Experience of the Multiple Myeloma Gimema Lazio Group

Federico Vozella, MD, Agostina Siniscalchi, MD, Manuela Rizzo, MD, Tommaso Za, MD, Giusy Antolino, MD, Ugo Coppetelli, MD, Alfonso Piciocchi, Alessandro Andriani, MD, Ombretta Annibali, MD, Luca De Rosa, Giuseppe Cimino, Giacinto La Verde, Valerio De Stefano, MD, Maria Cantonetti, MD, Tommaso Caravita di Toritto, MD, Robin Foà, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5634.
https://doi.org/10.1182/blood-2018-99-115463
Published: 2018
Journal Articles

Efficacy and Feasibility of Dose/Schedule-Adjusted Rd-R Vs. Continuous Rd in Elderly and Intermediate-Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients: RV-MM-PI-0752 Phase III Randomized Study

Alessandra Larocca, MD, Marco Salvini, MD, Lorenzo De Paoli, MD, Nicola Cascavilla, MD, Giulia Benevolo, MD, Monica Galli, MD, Vittorio Montefusco, MD, Tommaso Caravita di Toritto, MD, Anna Baraldi, MD, Stefano Spada, Nicola Giuliani, MD PhD, Chiara Pautasso, Stefano Pulini, MD, Sonia Ronconi, MD, Norbert Pescosta, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Claudia Cellini, MD, Patrizia Tosi, MD, Massimo Offidani, MD, Michele Cavo, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Sara Bringhen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 305.
https://doi.org/10.1182/blood-2018-99-111796
Published: 2018
Journal Articles

Once Weekly Versus Twice Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Pooled Analysis of Two Phase 1/2 Studies

Sara Bringhen, MD, Roberto Mina, MD, Maria Teresa Petrucci, MD, Lorenzo De Paoli, MD, Stelvio Ballanti, MD, Pellegrino Musto, MD, Massimo Offidani, MD, Stefano Spada, Giulia Benevolo, MD, Elena Ponticelli, Piero Galieni, MD, Michele Cavo, MD, Tommaso Caravita di Toritto, MD, Concetta Conticello, MD, Vittorio Montefusco, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Alessandra Larocca, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1990.
https://doi.org/10.1182/blood-2018-99-111252
Published: 2018
Journal Articles

Double Autologous Stem Cell Transplantation Significantly Prolongs Progression-Free Survival and Overall Survival in Comparison with Single Autotransplantation in Newly Diagnosed Multiple Myeloma: An Analysis of Phase 3 EMN02/HO95 Study

Michele Cavo, MD, Francesca Maria Gay, Francesca Patriarca, MD, Elena Zamagni, MD, Vittorio Montefusco, MD, Luca Dozza, Monica Galli, MD PhD, Sara Bringhen, Nicoletta Testoni, BSc, Mariella Grasso, MD, Stelvio Ballanti, MD, Paola Tacchetti, MD, Giampietro Semenzato, MD, Anna Marina Liberati, Giulia Benevolo, Mauro Spriano, MD, Paolo Di Bartolomeo, MD, Tommaso Caravita di Toritto, MD, Angelo D. Palmas, MD, Anna Maria Cafro, MD, Fortunato Morabito, MD, Pellegrino Musto, MD, Rita Rizzi, MD, Antonio Palumbo, MD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 401.
https://doi.org/10.1182/blood.V130.Suppl_1.401.401
Published: 2017
Journal Articles

Bortezomib-Dexamethasone Re-Treatment at Biochemical Relapse Vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II Multi-Center, Randomized Study

Roberto Mina, MD, Alessandra Larocca, Angelo Belotti, MD, Francesco Di Raimondo, MD, Anna Baraldi, MD, Massimo Offidani, MD, Monia Marchetti, MD, Roberto Ria, MD, Annarita Conconi, MD, Norbert Pescosta, MD, Mariella Grasso, MD, Giusy Cetani, MD, Anna Maria Cafro, MD, Roberto Passera, Rossella Troia, Gianpietro Semenzato, MD, Nicola Giuliani, MD PhD, Stelvio Ballanti, MD, Claudia Cellini, MD, Anna Marina Liberati, Tommaso Caravita di Toritto, MD, Maria Teresa Petrucci, MD, Pellegrino Musto, MD, Antonio Palumbo, MD, Pieter Sonneveld, MDPhD, Mario Boccadoro, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3128.
https://doi.org/10.1182/blood.V130.Suppl_1.3128.3128
Published: 2017
Journal Articles

An Integrated Analysis of Cardio-Vascular Adverse Events of Carfilzomib, Cyclophosphamide and Dexamethasone in Elderly Newly Diagnosed Myeloma Patients Enrolled in 3 Phase I/II Trials

Sara Bringhen, MD, Maria Teresa Petrucci, MD, Nicola Giuliani, MD, Angelo Michele Carella, MD, Mariella Genuardi, MD, Tommaso Caravita di Toritto, MD, Alessandra Malfitano, Pellegrino Musto, MD, Roberto Ria, MD, Giovannino Ciccone, MD PhD, Paola Omedé, Massimo Offidani, MD, Caterina Musolino, MD, Anna Marina Liberati, MD, Lorenzo De Paoli, MD, Stelvio Ballanti, MD, Piero Galieni, MD, Michele Cavo, MD, Concetta Conticello, MD, Roberto Foà, MD, Paolo Corradini, MD, Gianluca Gaidano, MD PhD, Antonio Palumbo, MD, Pieter Sonneveld, Mario Boccadoro, MD
Journal: Blood
Blood (2016) 128 (22): 3336.
https://doi.org/10.1182/blood.V128.22.3336.3336
Published: 2016
Journal Articles

Impact of Treatment Intensification According to Patient Prognosis: A Pooled Analysis of 3 Randomized Phase III Trials

Francesca Gay, MD, Mattia D'Agostino, MD, Roman Hajek, prof, MD PhD, Sara Bringhen, MD, Concetta Conticello, MD, Gianluca Gaidano, MD PhD, Vittorio Montefusco, Sara Pezzatti, MD, Marco Salvini, MD, Tommaso Caravita, MD, Anna Maria Cafro, MD, Michele Cavo, MD, Marina Ruggeri, Fortunato Morabito, MD, Roberto Mina, MD, Luca Baldini, MD Prof, Giulia Benevolo, MD, Tommasina Guglielmelli, MD, Annalisa Bernardini, Roberto Foà, MD, Francesca Patriarca, MD, Massimo Offidani, MD, Roberto Ria, MD, Dina Ben Yehuda, MD, Maria Teresa Petrucci, MD, Andrew Spencer, MD, Antonio Palumbo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2016) 128 (22): 995.
https://doi.org/10.1182/blood.V128.22.995.995
Published: 2016
Journal Articles

Real Life, Retrospective Analysis of Bortezomib Re-Use As Second Treatment for Relapsed Multiple Myeloma Patients Previously Exposed to Bortezomib-Based Therapies As First Line: The Rebound Study

Pellegrino Musto, MD, Vittorio Simeon, PhD, Nicola Cascavilla, MD, Antonietta Falcone, MD, Maria Teresa Petrucci, MD, Laura Cesini, MD, Francesco Di Raimondo, MD, Concetta Conticello, MD, Roberto Ria, MD, Lucio Catalano, MD, Dalila Salvatore, MD, Lucia Mastrullo, MD, Alfredo Gagliardi, MD, Oreste Villani, MD, Giuseppe Pietrantuono, MD, Giovanni D'Arena, MD, Giovanna Mansueto, MD, Andrea Patriarca, MD, Sara Bringhen, MD, Mariella Genuardi, MD, Nicola Di Renzo, MD, Giovanni Reddiconto, MD, Alberto Fragasso, MD, Tommaso Caravita, MD, Silvia Mangiacavalli, MD, Antonio Palumbo, MD, Alessandro Corso, MD
Journal: Blood
Blood (2016) 128 (22): 4494.
https://doi.org/10.1182/blood.V128.22.4494.4494
Published: 2016
Journal Articles

Autologous Transplantation Versus Cyclophosphamide-Lenalidomide-Prednisone Followed By Lenalidomide-Prednisone Versus Lenalidomide Maintenance in Multiple Myeloma: Long-Term Results of a Phase III Trial

Francesca Gay, Valeria Magarotto, MD, Maria Teresa Petrucci, Francesco Di Raimondo, Luděk Pour, Tommaso Caravita, Vlastimil Scudla, Anna Maria Cafro, Anna Marina Liberati, Stefano Spada, Maisnar Vladimir, Norbert Pescosta, Roberto Ria, Massimo Offidani, Sara Bringhen, Annalisa Bernardini, Francesca Patriarca, Paolo Corradini, Roberto Foà, Nicola Cascavilla, Lucio Catalano, Andrew Spencer, Roman Hajek, Mario Boccadoro, MD, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 392.
https://doi.org/10.1182/blood.V126.23.392.392
Published: 2015
Journal Articles

Impact of Complete Response on Survival with Either Autologous Stem Cell Transplantation or Conventional Chemotherapy: Results of a Pooled Analysis of 5 Phase III Trials in Newly Diagnosed Multiple Myeloma Patients

Roberto Mina, Alessandra Larocca, Massimo Offidani, Sara Bringhen, Tommaso Caravita, Valeria Magarotto, MD, Lucia Pantani, MD, Francesco Di Raimondo, Alberto Bosi, Iolanda D. Vincelli, Paola Tacchetti, MD, Gianluca Gaidano, Sonia Grandi, Caterina Musolino, Chiara Cerrato, Ludek Pour, Monica Astolfi, Giuseppe Rossi, MD, Fausto Rossini, Maria T. Petrucci, Roberto Ria, Annalisa Pezzi, PhD, Roman Hajek, Michele Cavo, Andrew Spencer, Mario Boccadoro, MD, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 927.
https://doi.org/10.1182/blood.V126.23.927.927
Published: 2015
Journal Articles

Minimal Residual Disease Detection By Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: A Preliminary Analysis of the EMN02/HO95 MM Study

Stefania Oliva, Manuela Gambella, Milena Gilestro, Francesca Gay, Alessandra Larocca, Anna Marina Liberati, Francesca Bonello, Giulia Benevolo, Giovannino Ciccone, Tommaso Caravita, Vittorio Emanuele Muccio, Simona Caltagirone, Stefano Spada, Barbara Gamberi, Simone Ferrero, Marina Ruggeri, Giuseppe Rossi, Elona Saraci, Massimo Offidani, Maria Teresa Petrucci, Mario Boccadoro, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, Paola Omedè
Journal: Blood
Blood (2015) 126 (23): 1760.
https://doi.org/10.1182/blood.V126.23.1760.1760
Published: 2015
Journal Articles

Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) in Italy: A Subanalysis of the Stratus Trial (MM-010)

Michele Cavo, Paolo Corradini, Francesco Di Raimondo, Mario Petrini, Anna Maria Cafro, Tommaso Caravita di Toritto, Massimo Offidani, Gianpietro Semenzato, Renato Zambello, Antonio Lazzaro, Maria Teresa Petrucci, Francesco Rodeghiero, Mathew Simcock, Ana Slaughter, Jennifer Herring, Teresa Peluso, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 5376.
https://doi.org/10.1182/blood.V126.23.5376.5376
Published: 2015